The short answer
Hims & Hers is generally halal as a core healthcare activity, but its current quantitative screen fails the examined total-assets debt limits. The company connects patients with clinicians and delivers prescription and over-the-counter treatments. That core healthcare activity is generally permissible, while the current filing shows a large convertible-note liability and a mixed product portfolio that needs more than a one-word answer.
This is a reproducible research screen, not a fatwa or investment recommendation. Scholars and providers can differ on debt definitions, total-assets versus market-cap denominators, product-level revenue classification and the treatment of interest income.
Current quantitative Sharia screen
Based on 10-Q figures for the period ended 2026-03-31; calculated 2026-07-13.
974.106 / 2,267.043
750.875 / 2,267.043
371.886 / 2,267.043
7.9 / 608.104
- Financial
- Fails
- Overall
- Fails
Interest-bearing debt is 42.97% of total assets, above the examined 33.333% limit. Liquidity is 33.12%, receivables plus cash are 16.40% and disclosed interest income is 1.30%; the debt result drives the financial failure.
- Financial
- Fails
- Overall
- Fails
Interest-bearing debt is 42.97% of total assets, above the examined 33.33% limit. Liquidity and receivables-plus-cash are below the examined total-assets limits, but the debt result fails the financial screen.
- Financial
- Fails
- Overall
- Fails
Interest-bearing debt is 42.97% of total assets, above the examined 33% limit; identifiable liquidity is 33.12%, just above that same limit. This is a calculation against SAC ratios, not an official SAC classification of a U.S.-listed security.
- Financial
- Not calculated
- Overall
- Not calculated
A properly licensed and reproducible historical market-cap series is not stored.
Business-activity disclosure
Hims & Hers operates a direct-to-consumer telehealth platform that connects users with clinicians and delivers prescription and over-the-counter products. Healthcare and treatment of medical conditions are generally permissible, while product-level and use-context questions require separate qualitative review.
Limitation: The filing reports total revenue and broad business metrics but does not allocate revenue by product, medical indication, contraception, sexual-health, cosmetic, mental-health or weight-management category in a way that produces a reproducible prohibited-revenue numerator.
Purification
The filing discloses 7.9 of interest income, or 1.30% of quarterly revenue, but this record does not prescribe a fixed purification amount because the preferred scholarly treatment of the company's mixed product revenue and investment income is not determined by a single universal standard.
Inputs, assumptions and primary sources
- Interest-bearing debt uses the 974.106 net carrying amount of the 0% 2030 Convertible Notes. No loans were outstanding under the revolving credit facility at March 31, 2026; operating leases and earn-out liabilities are not treated as interest-bearing debt in this input.
- Cash and cash equivalents use 222.266. Interest-bearing securities use 528.609 of short-term available-for-sale investments; the filing identifies government, government-agency and corporate-bond holdings.
- Receivables use the reported net balance of 149.620. The filing does not provide a separate trade-receivable subtotal for this screen.
- Quarterly revenue uses 608.104 for the three months ended March 31, 2026.
- The filing separately reports 7.9 of interest income and 2.9 of interest expense for the quarter; the gross interest-income line is used as the disclosed non-compliant-income input, without netting it against interest expense.
- Public reporting does not provide a reproducible prohibited-revenue numerator across sexual-health, contraception, cosmetic, mental-health, weight-management and other product categories.
This is a reproducible financial screen, not a fatwa. A failed total-assets screen can coexist with a pass under a market-cap methodology. ZakatInvest keeps the qualitative assessment separate so numerical thresholds do not erase material context.
Current quantitative screen
The calculations above use Hims & Hers' official filing (Form 10-Q for the quarter ended March 31, 2026). Amounts are in USD millions and use total assets as the denominator so the inputs can be reproduced from the filing.
- Interest-bearing debt / assets: 42.97%, using the $974.106 million net carrying amount of the 0% 2030 Convertible Notes. No loans were outstanding under the revolving credit facility at quarter end.
- Cash plus interest-bearing securities / assets: 33.12%, using cash of $222.266 million and short-term available-for-sale investments of $528.609 million.
- Receivables plus cash / assets: 16.40%, using net receivables of $149.620 million.
- Interest income / revenue: 1.30%, using separately disclosed interest income of $7.9 million against quarterly revenue of $608.104 million. Interest expense is not netted against that numerator.
The debt ratio is above the examined 33%–33.333% total-assets limits under FTSE Yasaar, MSCI's total-assets series and the Malaysia SAC calculation. Market-cap-denominator methods are not calculated because this site does not store a licensed, reproducible historical market-cap series for the filing date.
What Hims & Hers does
Hims & Hers operates a direct-to-consumer telehealth platform. It offers online consultations and delivery of prescription or over-the-counter products across hair loss, dermatology, sexual health, mental health, weight management, women's health and primary care. The filing reports $608.1 million of quarterly revenue and approximately 2.6 million subscribers, but it does not provide a product-by-product revenue table that can establish a prohibited-revenue percentage.
Treating recognized medical conditions and improving access to healthcare are generally permissible activities. The qualitative assessment therefore remains separate from the financial-ratio result: a permissible core business does not erase a failed debt screen, and a failed debt screen does not by itself make every healthcare service haram.
Qualitative considerations
- Sexual-health treatments: sildenafil and tadalafil are prescribed for erectile dysfunction. Some investors may still apply a more restrictive personal view, even where the use is medical and within marriage.
- Women's health and contraception: the Hers platform includes birth-control and other women's-health services. Islamic views vary by method, purpose and marital context, so the filing cannot resolve every individual question.
- Weight management: GLP-1 offerings are a meaningful growth area. The filing describes regulatory, inventory and fulfillment changes around weight-loss products; those are business and compliance risks, not automatically Sharia violations.
- Mental health and dermatology: antidepressants, anxiety treatments, hair-loss products and therapy address recognized health conditions. Public reporting does not split their revenue for a product-level screen.
- Cash and financing: Hims & Hers holds government, government-agency and corporate-bond investments and carries convertible notes. Interest-income treatment and debt classification should be reviewed again after the next filing.
How the methodologies differ
Under the FTSE Yasaar calculation reproduced here, the debt ratio fails while liquidity, receivables plus cash and the disclosed interest-income ratio are below the examined limits. The MSCI total-assets calculation also fails on debt. The Malaysia SAC financial-ratio calculation fails on debt and identifiable liquidity. These are calculations against named methods, not claims of official index membership or a universal scholarly ruling.
Bottom line
HIMS is presented as generally halal as a core healthcare activity, with a current financial screen failure. The main unresolved items are the large convertible-note balance, the absence of a reproducible product-level prohibited-revenue numerator and differences in how a scholar or screening provider treats healthcare categories and investment income.
If you are considering HIMS, compare this evidence with the methodology and scholar you follow, monitor the next filing and avoid relying on old ratio percentages or unsupported claims that all screening providers reach the same result.
The telehealth business is generally permissible, while the current debt ratio exceeds the examined total-assets limits.
Check another asset →